Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SODIUM PHENYLBUTYRATE
- Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
- Role of BCAA in Glucose Homeostasis
- A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate
- The Effects of Sodium Phenylbutyrate on Circulating Branched Chain Amino Acids
- Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome)
- Phenylbutyrate for STXBP1 Encephalopathy and SLC6A1 Neurodevelopmental Disorder
- Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency.
- Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
- Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders
- Phenylbutyrate in Proteinuric Nephropathies
- Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders
- Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
- Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)
- Phenylbutyrate Therapy for Maple Syrup Urine Disease
- Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
- Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)
- Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
- Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
- A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)
- Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders
- Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
- Effect of Endoplasmic Reticulum Stress on Metabolic Function
- Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders
- Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl
- Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
- Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
- 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
- Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
- Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)
- 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
- Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
- Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
- 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
- Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
- Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
- Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
Clinical trials list
click for details